Health Press Releases & Articles 321 - 325 of 771
Albireo Announces Positive Clinical Data On A3309 In Patients With Chronic Idiopathic Constipation
18th November 2009 -
Views: 676
Albireo today announced the completion of a phase 1b study showing a favourable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation.
Crestor(r) Reduced Risk Of Cardiovascular Events In Women By Nearly Half In New Analysis Of Jupiter
18th November 2009 -
Views: 636
JUPITER, which used CRESTOR 20 mg, is the first statin study to demonstrate a reduction in the risk of cardiovascular (CV) events in women without established cardiovascular disease (CVD).
Destination Therapy Trial Data Demonstrate Superiority For Heartmate Ii(r) Over Heartmate(r) Xve
18th November 2009 -
Views: 768
The data were presented at a late breaking clinical trial session of the 2009 Scientific Sessions of the American Heart Association by Dr. Joseph Rogers of Duke University on behalf of the HeartMate II investigators.
Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibr
17th November 2009 -
Views: 620
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the launch of the RealiseAF registry (Real Life global Survey Evaluating patients with Atrial Fibrillation), an international, cross-sectional, observational registry that will be conducted in patients with atrial fibrillation (AF).
Flibanserin Demonstrates Efficacy And Tolerability In Pivotal Phase Iii Trials In Pre-menopausal Wom
17th November 2009 -
Views: 616
Data from pooled, pivotal Phase III clinical trials demonstrate that flibanserin 100mg taken once daily at bedtime significantly increased the number of Satisfying Sexual Events (SSEs) and sexual desire while significantly decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD).
NEWS 
